Search Results - "ASCHNER, PABLO"

New IDF clinical practice recommendations for managing type 2 diabetes in primary care by Aschner, Pablo

Get full text

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS) by Aschner, Pablo, Gagliardino, Juan J., Ilkova, Hasan, Lavalle, Fernando, Ramachandran, Ambady, Mbanya, Jean Claude, Shestakova, Marina, Chantelot, Jean-Marc, Chan, Juliana C. N.

“…Aims/hypothesis We evaluated the secular trend of glycaemic control in individuals with type 2 diabetes in developing countries, where data are limited…”
Get full text

Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study) by Nazare, Julie-Anne, PhD, Smith, Jessica, PhD, Borel, Anne-Laure, MD, PhD, Aschner, Pablo, MD, Barter, Phil, MD, PhD, Van Gaal, Luc, MD, PhD, Tan, Chee Eng, MD, PhD, Wittchen, Hans-Ulrich, PhD, Matsuzawa, Yuji, MD, PhD, Kadowaki, Takashi, MD, PhD, Ross, Robert, PhD, Brulle-Wohlhueter, Claire, MD, Alméras, Natalie, PhD, Haffner, Steven M., MD, Balkau, Beverley, PhD, Després, Jean-Pierre, PhD

“…Despite its well-documented relation with visceral adiposity (VAT) and cardiometabolic risk (CMR), whether waist circumference (WC) should be measured in…”
Get full text

Recent advances in understanding/managing type 2 diabetes mellitus [version 1; peer review: 3 approved] by Aschner, Pablo

“…The treatment of type 2 diabetes mellitus has evolved in the present century toward safer and maybe more effective drugs, which in some cases can also reduce…”
Get full text

Obesity and COVID‐19 in Latin America: A tragedy of two pandemics—Official document of the Latin American Federation of Obesity Societies by Halpern, Bruno, Louzada, Maria Laura da Costa, Aschner, Pablo, Gerchman, Fernando, Brajkovich, Imperia, Faria‐Neto, José Rocha, Polanco, Felix Escaño, Montero, Julio, Juliá, Silvia María Marín, Lotufo, Paulo Andrade, Franco, Oscar H.

“…Summary In May 2020, Latin America became the epicenter of the COVID‐19 pandemic, a region already afflicted by social disparities, poor healthcare access,…”
Get full text

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery by Khunti, Kamlesh, Aroda, Vanita R, Aschner, Pablo, Chan, Juliana C N, Del Prato, Stefano, Hambling, Clare E, Harris, Stewart, Lamptey, Roberta, McKee, Martin, Tandon, Nikhil, Valabhji, Jonathan, Seidu, Samuel

“…The COVID-19 pandemic has disproportionately affected certain groups, such as older people (ie, >65 years), minority ethnic populations, and people with…”
Get full text

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes by Aschner, Pablo, Kipnes, Mark S, Lunceford, Jared K, Sanchez, Matilde, Mickel, Carolyn, Williams-Herman, Debora E

“…OBJECTIVE:--To examine the efficacy and safety of once-daily oral sitagliptin as monotherapy in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS--In…”
Get full text

Effects of Performing Morning Versus Afternoon Exercise on Glycemic Control and Hypoglycemia Frequency in Type 1 Diabetes Patients on Sensor-Augmented Insulin Pump Therapy by Gomez, Ana Maria, Gomez, Claudia, Aschner, Pablo, Veloza, Angelica, Muñoz, Oscar, Rubio, Claudia, Vallejo, Santiago

“…Background: Although physical exercise (PE) is recommended for individuals with type 1 diabetes (DM1), participation in exercise is challenging because it…”
Get full text

Editorial: Population and clinical strategies for the prevention of type 2 diabetes: what's new? by Schmidt, Maria Inês, Aschner, Pablo, Bracco, Paula Andreghetto, Herman, William H

Get full text

Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS) by Mbanya, Jean Claude, Aschner, Pablo, Gagliardino, Juan J., İlkova, Hasan, Lavalle, Fernando, Ramachandran, Ambady, Chantelot, Jean-Marc, Chan, Juliana C. N.

“…Aims/hypothesis Diabetes is the leading cause of kidney disease worldwide. There is limited information on screening, treatment and control of kidney disease…”
Get full text

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial by Aschner, Pablo, Prof, Chan, Juliana, Prof, Owens, David R, Prof, Picard, Sylvie, MD, Wang, Edward, PhD, Dain, Marie-Paule, MD, Pilorget, Valérie, MD, Echtay, Akram, MD, Fonseca, Vivian, Prof

“…Summary Background In people with type 2 diabetes, a dipeptidyl peptidase-4 (DPP-4) inhibitor is one choice as second-line treatment after metformin, with…”
Get full text

Metabolic memory for vascular disease in diabetes by Aschner, Pablo J, Ruiz, Alvaro J

“…Although the terms "metabolic memory" and "legacy effect" have been used to describe the prolonged benefits of good blood glucose control, the former is now…”
Get more information

Correction to: Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS) by Aschner, Pablo, Gagliardino, Juan J., Ilkova, Hasan, Lavalle, Fernando, Ramachandran, Ambady, Mbanya, Jean Claude, Shestakova, Marina, Chantelot, Jean-Marc, Chan, Juliana C. N.

“…Unfortunately, the standard deviations for ‘last HbA 1c measurement’ in mmol/mol were miscalculated in Table 1 of this paper…”
Get full text

Health-related quality of life (HRQoL) in a population at risk of type 2 diabetes: a cross-sectional study in two Latin American cities by Anillo Arrieta, Luis A, Acosta Vergara, Tania, Tuesca, Rafael, Rodríguez Acosta, Sandra, Flórez Lozano, Karen C, Aschner, Pablo, Gabriel, Rafael, De La Rosa, Sandra, Nieto Castillo, Julieth P, Barengo, Noël C

“…The purpose of this study was to describe the health-related quality of life (HRQoL) characteristics in a population at risk of developing type 2 diabetes in…”
Get full text

Patient‐reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study by Chan, Juliana CN, Mbanya, Jean Claude, Chantelot, Jean‐Marc, Shestakova, Marina, Ramachandran, Ambady, Ilkova, Hasan, Deplante, Lucille, Rollot, Melissa, Melas‐Melt, Lydie, Gagliardino, Juan Jose, Aschner, Pablo

“…Aims/Introduction We analyzed patient‐reported outcomes of people with type 2 diabetes to better understand perceptions and experiences contributing to…”
Get full text

Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC) by Ballesteros-Ramírez, Ricardo, Pinilla, Paola, Sanchéz, Jesús, Torregrosa, Lilian, Aschner, Pablo, Urueña, Claudia, Fiorentino, Susana

“…Background Chemotherapy in breast cancer is effective but can generate significant toxicity and lead to tumor resistance. Joint treatment with standardized…”
Get full text

Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults by M., Pablo Aschner, V., Oscar Mauricio Muñoz, Girón, Diana, García, Olga Milena, Fernández-Ávila, Daniel, Casas, Luz Ángela, Bohórquez, Luisa Fernanda, T., Clara María Arango, Carvajal, Liliana, Ramírez, Doris Amanda, Sarmiento, Juan Guillermo, Colon, Cristian Alejandro, G., Néstor Fabián Correa, R., Pilar Alarcón, S., Álvaro Andrés Bustamante

“…In Colombia, diabetes mellitus is a public health program for those responsible for creating and implementing strategies for prevention, diagnosis, treatment,…”
Get full text

Exploring the safety and efficacy of phytomedicine Petiveria alliacea extract (Esperanza) in patients with metastatic gastrointestinal tumors and acute leukemias: study protocol for a phase Ib/randomized double blind phase II trial (PA001) by Ballesteros-Ramírez, Ricardo, Pinilla, Paola, Sanchéz, Jesús, Arévalo, Mónica, Sanchez, Elio, Aschner, Pablo, Urueña, Claudia, Fiorentino, Susana

“…The energy metabolism of drug-resistant tumor cells can provide a survival advantage during therapy, and treatment itself may influence metabolic…”
Get full text

Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et) by Urueña, Claudia, Ballesteros-Ramírez, Ricardo, Gomez-Cadena, Alejandra, Barreto, Alfonso, Prieto, Karol, Quijano, Sandra, Aschner, Pablo, Martínez, Carlos, Zapata-Cardona, Maria I., El-Ahanidi, Hajar, Jandus, Camilla, Florez-Alvarez, Lizdany, Rugeles, Maria Teresa, Zapata-Builes, Wildeman, Garcia, Angel Alberto, Fiorentino, Susana

“…BackgroundIt has been proposed that polyphenols can be used in the development of new therapies against COVID-19, given their ability to interfere with the…”
Get full text

Transculturalizing Diabetes Prevention in Latin America by Nieto-Martínez, Ramfis, González-Rivas, Juan P., Aschner, Pablo, Barengo, Noël C., Mechanick, Jeffrey I.

“…Type 2 diabetes (T2D) imposes a heavy burden in developing countries, requiring effective primary prevention policies. Randomized clinical trials have…”
Get full text